glp 1 liver Revolutionizing MASLD treatment with GLP-1 receptor agonists GLP-1R and Diabetes

This provides a clear view into how these therapies are being integrated into diabetes care at scale and highlights the value of Marketplace data for tracking treatment adoption and patient outcomes in real time (Figure 1)

Marko M, Pawliczak R

Marketed as a convenient, needle-free alternative to the in-demand injectables, these patches claim to help people lose weight without injections or prescriptions

With dual and triple agonists, clinical studies are now achieving results that are otherwise only known from bariatric surgery

( 10.1016/S2213-8587(1630010-9) [DOI] [PubMed] [Google Scholar] Grunberger G Chang A Garcia Soria G Botros FT Bsharat R & Milicevic Z

A few small clinical studies and observational reports indicate that individuals treated with GLP1 RAs may report reduced alcohol cravings and lower consumption levels